Cambridge Heart MTWA Could Stratify ICD Population Into High/Low Risk

Trials of Cambridge Heart's Microvolt T-Wave Alternans (MTWA) test in patients with left ventricular dysfunction suggest that approximately one-third of patients indicated for an ICD under the MADIT-II criteria may not benefit from ICD therapy